CSIMarket
 


Regenerx Biopharmaceuticals Inc  (RGRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Regenerx Biopharmaceuticals Inc's Quick Ratio for Trailing Twelve Months Period

RGRX's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



RGRX Quick Ratio for Trailing Twelve Months Period

(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Growth 52.59 % -23.02 % -12.24 % -73.82 % -76.33 %
Y / Y Cash & cash equivalent Growth -7.21 % 169.71 % 122.66 % 76.64 % -28.25 %
Quick Ratio for Trailing Twelve Months Period 3.52 3.99 3.23 2.61 1.31
Total Ranking # 603 # 653 # 730 # 916 # 1167
Seq. Current Liabilities Growth 15.63 % 10.88 % 11.14 % 7.08 % -41.66 %
Seq. Cash & cash equivalent Growth -3.93 % -27.43 % -24.68 % 76.69 % 179.26 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the I. Quarter to $0 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 3.52 below Regenerx Biopharmaceuticals Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 108 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Regenerx Biopharmaceuticals Inc. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 603, from total ranking in previous quarter at 653.

What is Quick Ratio?
Learn more about RGRX
Quick Ratio RGRX in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 109
Sector # 331
S&P 500 # 594


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.58 1.46 0.26
(Dec 31 2019)   (Dec 31 2017)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2020, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Rapt Therapeutics Inc   9.50 
Enzon Pharmaceuticals Inc   9.28 
Cohbar Inc   9.28 
Immunomedics Inc   9.22 
Proteostasis Therapeutics Inc   9.21 
Evelo Biosciences Inc   9.13 
Arcus Biosciences Inc   9.11 
Fennec Pharmaceuticals Inc   8.77 
Unity Biotechnology Inc   8.76 
Cannabics Pharmaceuticals Inc   8.54 
Seneca Biopharma Inc   8.38 
Aim Immunotech Inc   8.09 
Gritstone Oncology Inc   7.84 
Alder Biopharmaceuticals Inc  7.82 
Diffusion Pharmaceuticals Inc   7.71 
Neogen Corp  7.68 
Surface Oncology Inc   7.66 
Atara Biotherapeutics Inc   7.56 
Tracon Pharmaceuticals Inc   7.53 
Catalyst Biosciences Inc   7.42 
Intellia Therapeutics Inc   7.39 
Eiger Biopharmaceuticals Inc   7.30 
Protokinetix Inc   7.30 
Arca Biopharma Inc   7.23 
Fulgent Genetics Inc   7.16 
Capricor Therapeutics Inc   7.10 
Cocrystal Pharma Inc   6.89 
Applied Genetic Technologies Corp  6.87 
Vir Biotechnology Inc   6.53 
Protara Therapeutics Inc   6.46 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HOME's Profile

Stock Price

HOME's Financials

Business Description

Fundamentals

Charts & Quotes

HOME's News

Suppliers

HOME's Competitors

Customers & Markets

Economic Indicators

HOME's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071